glp 1 with medicaid online High cost of weight-loss drugs strains state programs Medicaid Coverage of and Spending

Tirzepatide is a revolutionary dual-receptor agonist that offers unprecedented weight loss, glycemic control, and metabolic health benefits

Safer DL, Adler S, Dalai SS, Bentley JP, Toyama H, Paraito S, Najarian T

doi: 10.3390/medicina55060233 [DOI] [PMC free article] [PubMed] [Google Scholar] 164

For me, this has felt like giving my metabolism a soft place to land while my hormones do their midlife rollercoaster dance

(2022) Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review

Clinical trials demonstrate reductions in alanine aminotransferase (ALT) and aspartate aminotransferase (AST)key markers of liver healthoften correlating with decreased hepatic fat accumulation